Related Experiment Video
Updated: May 26, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
[Intravitreal ranibizumab for diabetic macula edema].
Vestnik Oftalmologii
|December 15, 2011
Summary
Intravitreal ranibizumab (Lucentis) injections significantly improved visual acuity and reduced retinal thickness in patients with diabetic macular edema (DME). This treatment demonstrated a favorable safety profile, offering a viable option for DME management.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Context:
- Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
- Intravitreal anti-VEGF therapy is a common treatment for DME.
Purpose:
- To evaluate the efficacy and safety of intravitreal ranibizumab (Lucentis) in patients with DME.
Summary:
- 25 DME patients received 0.5 mg intravitreal ranibizumab injections (mean 1.7).
- Visual acuity improved significantly post-treatment (p < 0.001).
- Central retinal thickness decreased significantly (p < 0.05), with no adverse effects observed.
Impact:
- Intravitreal ranibizumab effectively stabilizes and improves vision in DME patients.
- The treatment offers a safe therapeutic option for managing diabetic macular edema.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...